REVIEW PAPER
Cigarette Smoking as a Risk Factor of Coronary Artery Disease and its Effects on Platelet Function
Teruo Inoue 1  
 
 
More details
Hide details
1
Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya City, Saitama, Japan
CORRESPONDING AUTHOR
Teruo Inoue   

Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, 2-1-50 Minamikoshigaya, Koshigaya City, Saitama 343-8555, Japan
Publish date: 2004-03-15
 
Tobacco Induced Diseases 2004;2(March):27
KEYWORDS
ABSTRACT
It has been well established that cigarette smoking is a powerful risk factor for coronary artery disease. A number of epidemiologic studies have shown a strong association between cigarette smoking and atherosclerosis, myocardial infarction and death from coronary artery disease. In addition to active smoking, passive smoking can also carry a risk of coronary artery disease. Although the detailed mechanism through which cigarette smoking is associated with cardiovascular disease has not yet been clarified, it is suggested that cigarette smoking is related to thrombogenesis, as well as atherogenesis, and blood platelet behavior is thought to be prominent among the proposed mechanisms involved in atherogenesis and thrombogenesis. The following is a review of evidence that cigarette smoking affects platelet function.
 
REFERENCES (46)
1.
Levine PH: An acute effect of cigarette smoking on platelet function: – a possible link between smoking and arterial thrombosis. Circulation. 1973, 48: 619-623.
 
2.
Renaud S, Blanche D, Dumont E, Thevenon C, Wissendanger T: Platelet function after cigarette smoking in relation to nicotin and carbon monoxide. Clin Pharmacol Ther. 1984, 36: 389-395.
 
3.
Schmidt KG, Rasmussen JW: Acute platelet activation induced by smoking – in vivo and ex-vivo studies in humans. Thromb Heamost. 1984, 51: 279-282.
 
4.
Blache D, Bouthillier D, Davignon J: Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis. 1992, 93: 179-188. 10.1016/0021-9150(92)90254-E.
 
5.
Siess W, Lorenz R, Roth P, Weber PC: Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion. Circulation. 1982, 66: 44-48.
 
6.
Laszlo E, Kaldi N, Kovacs L: Alteration in plasma proteins and platelet functions with aging and cigarette smoking in helthy men. Thromb Haemost. 1983, 49: 150.
 
7.
Pittilo RM, Clarke JMF, Harris D: Cigarette smoking and platelet adhesion. Br J Haematol. 1984, 58: 627-632. 10.1111/j.1365-2141.1984.tb06109.x.
 
8.
Beswick A, Renaud S, Yarnell JWG, Elwood PC: Platelet activity in habitual smokers. Thromb Haemost. 1991, 66: 739-740.
 
9.
Foo LC, Roshidah I, Aimy MB: Platelets of habitual smokers have reduced susceptibility to aggregating agents. Thromb Haemost. 1991, 65: 317-319.
 
10.
Lassila R, Laustiola KE: Physical exercise provokes platelet desensitization in men who smoke cigarettes: involvement of sympathoadrenergic mechanisms: a study of monozygotic twin pairs discordant for cigarette smoking. Thromb Res. 1988, 51: 145-155. 10.1016/0049-3848(88)90058-8.
 
11.
Elwood PC, REnaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell JWG: Ischemic heart disease and platelet aggregation – the Caerphilly Collaborative Heart Disease Study. Circulation. 1991, 83: 38-44.
 
12.
Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y: Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res. 1999, 93: 271-278. 10.1016/S0049-3848(98)00184-4.
 
13.
Fusegawa Y, Handa S: Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res. 2000, 97: 287-295. 10.1016/S0049-3848(99)00137-1.
 
14.
Inoue T, Hayashi M, Uchida T, Takayanagi K, Hayashi T, Morooka S: Significance of platelet aggregability immediately after blood sampling and effect of cigarette smoking. Platelets. 2001, 12: 415-418. 10.1080/09537100120071068.
 
15.
Mustard JF: Effect of smoking on blood coagulation and platelet survival in man. Br Med J. 1963, 1: 846-849. 10.1136/bmj.1.5334.846.
 
16.
Fuster V, Chesboro JH, Frye R, Elveback LR: Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation. 1983, 63: 546-551.
 
17.
FitzGerald GA, Pedersen AK, Patrono C: Analysis of prostacyclin and thromboxane A2 biosynthesis in cardiovascular disease [Editorial]. Circulation. 1983, 67: 1174-1177.
 
18.
Dotevall A, Kutti J, Teger-Nilsson AC, Wadenvik H, Wihelmsen L: Platelet reactivity, fibrinogen and smoking. Eur J Haemotology. 1987, 38: 55-59.
 
19.
Stenberg PE, McEver RP, Shuman MA, Jaques YV, Bainton DF: A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985, 101: 880-886. 10.1083/jcb.101.3.880.
 
20.
Inoue T, Sohma R, Morooka S: Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vivo. Thromb Res. 1999, 93: 137-143. 10.1016/S0049-3848(98)00172-8.
 
21.
Nair S, Kulkarni S, Camoens HMT, Ghosh K, Mohanty D: Changes in platelet glycoprotein receptors after smoking – a flow cytometric study. Platelets. 2001, 12: 20-26. 10.1080/09537100120046020.
 
22.
Shattil SJ, Hoxie JA, Cunningham M, Brass LF: Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Cell Biol. 1985, 260: 11107-11114.
 
23.
Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today. 1993, 14: 506-512. 10.1016/0167-5699(93)90267-O.
 
24.
Pernerstorfer T, Stohlawetz P, Stummvoll G, Kapiotis S, Szekeres T, Eichler HG, Jilma B: Low-dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol. 1998, 102: 1229-1231. 10.1046/j.1365-2141.1998.00883.x.
 
25.
Fischer J, Bernutz C, Meier H, Weber PC: Formation of prostacyclin, and thromboxane in man as measured by the main urinary metabolites. Biochim Biophys Acta. 1986, 876: 194-198.
 
26.
Nowak J, Murray JJ, Oates JA, FitzGerald GA: Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 1987, 76: 6-14.
 
27.
FitzGerald GA, Oates JA, Nowak J: Cigarette smoking and hemostatic function. Am Heart J. 1988, 115: 267-271. 10.1016/0002-8703(88)90648-5.
 
28.
Radomski MW, Palmer RMJ, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Aci USA. 1990, 87: 5193-5197. 10.1073/pnas.87.13.5193.
 
29.
Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathphysiology, and pharmacology. Pharmacol Rev. 1991, 43: 109-1142.
 
30.
Freedman JE, Mickelson AM, Barnard MR: Nitric oxide release from activated platelets inhibit platelet recruitment. J Clin Invest. 1997, 100: 350-356. 10.1172/JCI119540.
 
31.
Freedman JE, Ting B, Hankin B: Impaired platelet production of nitric oxide predicts presence of acute coronary syndrome. Circulation. 1998, 98: 1481-1486.
 
32.
Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T: Augumented oxidative stress of platelets in chronic smokers. J Am Coll Cardiol. 2001, 38: 1320-1327. 10.1016/S0735-1097(01)01583-2.
 
33.
Glanzs SA, Parmley WW: Passive smoking and heart disease: epidemiology, physiology and biochemistry. Circulation. 1991, 83: 1-12.
 
34.
Wells AJ: Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994, 24: 546-554.
 
35.
Kritz H, Schmid P, Sinzinger H: Passive smoking and cardiovascular risk. Arch Intern Med. 1995, 155: 1942-1948. 10.1001/archinte.155.18.1942.
 
36.
Law MR, Morris JK, Wald NJ: Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. Br Med J. 1997, 18: 973-980.
 
37.
Sinzinger H, Virgolini I: Are passive smokers at greater risk of thrombosis?. Wien Wochenschr. 1989, 101: 694-698.
 
38.
Burghuber OC, Punzengruber C, Sinzinger H, Harber P, Slberbauer K: Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1985, 90: 34-38. 10.1378/chest.90.1.34.
 
39.
Davis JW, Shelton L, Watanabe TS, Arnold J: Passive smoking affects endothelium and platelets. Arch Intern Med. 1989, 149: 386-389. 10.1001/archinte.149.2.386.
 
40.
Davis JW, Hartmann CR, Lewis HD, Shelton L, Eigenberg D, Hassanein K, Hignite C, Ruttinger H: Cigarette smoking-induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med. 1985, 105: 479-483.
 
41.
Davis JW, Shelton L, Eigenberg D, Hignite C, Watanabe I: Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther. 1985, 37: 529-533.
 
42.
Davis JW, Shelton L, Hartmann CR, Eigenberg D, Ruttinger H: Smoking induced changes in endothelium and platelets are not affected by hydroxyethylrutosides. Br J Ekp Pathol. 1986, 37: 765-771.
 
43.
Davis JW, Shelton L, Eigenberg D: Lack of effect of aspirin on cigarette smoke-induced increase in circulating endothelial cells. Haemostasis. 1987, 17: 66-69.
 
44.
Zhu B-Q, Sun Y-P, Sievers R, Isenberg R, Glanz SA, Parmley WW: Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993, 21: 225-232.
 
45.
Sun Y-P, Zhu B-Q, Sievers R, Glanz SA, Parmley WW: Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation. 1994, 89: 2260-2265.
 
46.
Zhu B-Q, Sun Y-P, Sievers R, Glanz SA, Parmley WW, Wolfe CL: Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation. 1994, 89: 1282-1290.
 
 
CITATIONS (10):
1.
Comparative Effects ofα-,β-, andγ-Carbolines on Platelet Aggregation and Lipid Membranes
Hironori Tsuchiya
Journal of Toxicology
 
2.
Flow cytometric analysis of platelets type 2 diabetes mellitus reveals ‘angry’ platelets
Prashilla Soma, Albe Carina Swanepoel, Jeanette Noel du Plooy, Thandi Mqoco, Etheresia Pretorius
Cardiovascular Diabetology
 
3.
Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome
Johanna Tolva, Riitta Paakkanen, Hanna Jarva, Pirkko Pussinen, Aki S. Havulinna, Veikko Salomaa, Juha Sinisalo, Marja-Liisa Lokki
Atherosclerosis
 
4.
Increased risk of congestive heart failure in patients with acetaminophen poisoning: A nationwide cohort study
Wei-Sheng Chung, Cheng-Li Lin
Journal of Applied Toxicology
 
5.
Association of tobacco use and cessation with coronary atherosclerosis
Michael K. Cheezum, Alexander Kim, Marcio S. Bittencourt, David Kassop, Alexander Nissen, Dustin M. Thomas, Binh Nguyen, Robert J. Glynn, Nishant R. Shah, Todd C. Villines
Atherosclerosis
 
6.
Cardiovascular Sequelae of Tobacco Smoking
Kenneth J. Rempher
Critical Care Nursing Clinics of North America
 
7.
The risk of coronary artery disease estimated non-invasively in patients with essential hypertension environmentally exposed to cigarette smoke
Paweł Gać, Przemysław Jaźwiec, Małgorzata Poręba, Grzegorz Mazur, Krystyna Pawlas, Małgorzata Sobieszczańska, Rafał Poręba
Environmental Toxicology and Pharmacology
 
8.
Decreased VASP phosphorylation in platelets of male and female smokers of young age
Alice Assinger, Werner Schmid, Ivo Volf
Platelets
 
9.
Intraluminal Thrombus, Intraplaque Hemorrhage, Plaque Thickness, and Current Smoking Optimally Predict Carotid Stroke
J. Scott McNally, Michael S. McLaughlin, Peter J. Hinckley, Scott M. Treiman, Gregory J. Stoddard, Dennis L. Parker, Gerald S. Treiman
Stroke
 
10.
Relationship between serum high sensitivity C‐reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors
Mohammad Tajfard, Seyedeh Belin Tavakoly Sany, Amir Avan, Latiffah A. Latiff, Hamid Reza Rahimi, Mohsen Moohebati, Mehdi Hasanzadeh, Hamideh Ghazizadeh, Habibollah Esmaeily, Hassan Doosti, Ali Taghipour, Majid Ghayour‐Mobarhan, Gordon A. Ferns, Marzie Emamian, Mohd Sokhini Bin Abd Mutalib
Journal of Cellular Physiology
 
eISSN:1617-9625